πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8158675

Compounds and methods for the treatment or prevention of Flavivirus infections

Vertex Pharmaceuticals (Canada) Incorporated Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8158637

Quinazolines useful as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153668

Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)urei

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153655

Compositions useful as inhibitors of voltage-gated sodium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153642

Quinazolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143297

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129546

Derivatives for modulation of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129399

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129387

Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8129381

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8124781

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119631

Inhibitors of interleukin-1Ξ² converting enzyme

Vertex Pharmaceuticals Incorporated Β· Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101770

Pyridones useful as inhibitors of kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8101767

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097636

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093392

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076357

Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8076343

Benzimidazoles useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071618

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067606

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067417

Imidazo[1,2-F]pteridines useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8058271

Selective inhibitors of rock protein kinase and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039661

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8039623

Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

Vertex Pharmaceuticals Incorporated Β· Granted Tue Oct 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted